Serum troponin, D-dimer, and CRP level in severe coronavirus (COVID-19) patients

Ayad M Ali1, Hassan M Rostam2,3, Mohammed H Fatah4

  • 1Department of Chemistry, College of Sciences, University of Garmian, Kalar, Kurdistan Region, Iraq.

Insights

Elevated troponin, C-reactive protein (CRP), and D-dimer levels indicate higher COVID-19 mortality risk. These biomarkers, along with white blood cells (WBCs), were significantly higher in deceased patients and families experiencing multiple losses.

Area of Science:

  • Biochemistry
  • Immunology
  • Infectious Diseases

Background:

  • Abnormal levels of inflammation and coagulation biomarkers, including troponin, C-reactive protein (CRP), and D-dimer, are associated with coronavirus disease 2019 (COVID-19) progression.
  • These biomarkers play a role in the disease's severity and outcomes.

Purpose of the Study:

  • To investigate the correlation of troponin, CRP, D-dimer, white blood cell (WBC), and polymerase chain reaction-cycle threshold (PCR-Ct) values in COVID-19 survivors versus deceased patients.
  • To assess differences in these parameters between survivors and non-survivors.
  • To examine biomarker correlations within families who experienced multiple COVID-19 related deaths and compare them to a control group.

Main Methods:

  • Retrospective analysis of biomarker levels (troponin, CRP, D-dimer, WBC) and PCR-Ct in COVID-19 patients.
  • Comparison of biomarker levels between survivor and deceased groups.
  • Correlation analysis within affected families and comparison with an unrelated control group.

Main Results:

  • Significant differences in D-dimer, CRP, and troponin levels were observed between survivor and deceased groups during the first week of hospitalization.
  • By the second week, all studied parameters (troponin I, D-dimer, CRP, WBCs) showed significant differences between the groups.
  • WBC levels positively correlated with CRP in male survivors and with troponin in deceased male patients. In families with multiple deaths, troponin correlated positively with D-dimer, CRP, and WBCs during the second week.

Conclusions:

  • Troponin, D-dimer, CRP, and WBC levels were significantly higher in non-survivors compared to survivors of COVID-19.
  • Elevated troponin and WBC levels were notably associated with families experiencing multiple COVID-19 related deaths compared to controls.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
390
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
40
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
252
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
108
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
118
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
63